BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38678629)

  • 21. A feedback loop between GATA2-AS1 and GATA2 promotes colorectal cancer cell proliferation, invasion, epithelial-mesenchymal transition and stemness via recruiting DDX3X.
    Pan Y; Zhu Y; Zhang J; Jin L; Cao P
    J Transl Med; 2022 Jun; 20(1):287. PubMed ID: 35752837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDX11-AS1 contributes to osteosarcoma progression via stabilizing DDX11.
    Zhang H; Lin J; Chen J; Gu W; Mao Y; Wang H; Zhang Y; Liu W
    Life Sci; 2020 Aug; 254():117392. PubMed ID: 32014424
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Liu J; Yang X; Gao S; Wen M; Yu Q
    Pharmacogenomics; 2023 Feb; 24(3):163-172. PubMed ID: 36779347
    [No Abstract]   [Full Text] [Related]  

  • 24. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
    Zhang Z; Li SY; Zhang LB
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Non-Coding RNA ZEB1-Antisense 1 Affects Cell Migration and Invasion of Cervical Cancer by Regulating Epithelial-Mesenchymal Transition via the p38MAPK Signaling Pathway.
    Gan L; Chen Y; Liu H; Ju WH
    Gynecol Obstet Invest; 2019; 84(2):136-144. PubMed ID: 30253398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA Opa interacting protein 5-antisense RNA 1 (OIP5-AS1) promotes the migration, invasion and epithelial-mesenchymal transition (EMT) through targeting miR-147a/insulin-like growth factor 1 receptor (IGF1R) pathway in cervical cancer tissues and cell model.
    Zhang L; Cai Y; Tian C; Li Y; Ma K; Gao X; Liu L; Jiang Y; Wen W; Ma Z
    J Obstet Gynaecol Res; 2022 May; 48(5):1222-1232. PubMed ID: 35233882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
    Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
    Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
    Cui F; Luo P; Bai Y; Meng J
    Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
    Tian JB; Cao L; Dong GL
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
    Li Y; Zhuang W; Huang M; Li X
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
    Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis.
    Ren Z; Liu X; Si Y; Yang D
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):572-583. PubMed ID: 32054332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.
    Li H; Zhang GY; Pan CH; Zhang XY; Su XY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA DDX11-AS1: a novel oncogene in human cancer.
    Feng Y; Wu M; Hu S; Peng X; Chen F
    Hum Cell; 2020 Oct; 33(4):946-953. PubMed ID: 32772230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA TFAP2A-AS1 Inhibits Cell Proliferation and Invasion in Breast Cancer via miR-933/SMAD2.
    Zhou B; Guo H; Tang J
    Med Sci Monit; 2019 Feb; 25():1242-1253. PubMed ID: 30768589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1.
    Gao Z; Li S; Zhou X; Li H; He S
    Cancer Med; 2020 Oct; 9(20):7695-7705. PubMed ID: 32862492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA DLGAP1 antisense RNA 1 accelerates glioma progression via the microRNA-628-5p/DEAD-box helicase 59 pathway.
    Hu KQ; Ao XS
    Clinics (Sao Paulo); 2022; 77():100002. PubMed ID: 35113786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
    Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.